Cargando…

Evaluación subjetiva de las alteraciones del olfato y del gusto en pacientes con afectación leve por COVID-19 en España

BACKGROUND: Has been described the loss of smell and taste as onset symptoms in SARS-CoV-2. The objective of this study was to investigate the prevalence in Spain. METHODS: Prospective study of COVID-19 confirmed patients through RT-PCR in Spain. Patients completed olfactory and gustatory questionna...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninchritz-Becerra, Elisabeth, Soriano-Reixach, María Montserrat, Mayo-Yánez, Miguel, Calvo-Henríquez, Christian, Martínez-Ruiz de Apodaca, Paula, Saga-Gutiérrez, Carlos, Parente-Arias, Pablo, Villareal, Itzhel María, Viera-Artiles, Jaime, Poletti-Serafini, Daniel, Alobid, Isam, Ayad, Tareck, Saussez, Sven, Lechien, Jerome R., Chiesa-Estomba, Carlos M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518165/
https://www.ncbi.nlm.nih.gov/pubmed/33168151
http://dx.doi.org/10.1016/j.medcli.2020.08.004
Descripción
Sumario:BACKGROUND: Has been described the loss of smell and taste as onset symptoms in SARS-CoV-2. The objective of this study was to investigate the prevalence in Spain. METHODS: Prospective study of COVID-19 confirmed patients through RT-PCR in Spain. Patients completed olfactory and gustatory questionnaires. RESULTS: A total of 1043 patients with mild COVID-19 disease. The mean age was 39 ± 12 years. 826 patients (79.2%) described smell disorder, 662 (63.4%) as a total loss and 164 (15.7%) partial. 718 patients (68.8%) noticed some grade of taste dysfunction. There was a significant association between both disorders (p< .001). The olfactory dysfunction was the first symptom in 17.1%. The sQOD-NS scores were significantly lower in patients with a total loss compare to normosmic or hyposmic individuals (p = .001). Female were significantly more affected by olfactory and gustatory dysfunctions (p< .001). The early olfactory recover in 462 clinically cured patients was 315 (68.2%), during the first 4 weeks. CONCLUSION: The sudden onset smell and/or taste dysfunction should be considered highly suspicious for COVID-19 infection.